Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Preexposure Prophylaxis for HIV - Where Do We Go from Here?
NEJM 367:459-461,462, Cohen, M.S. & Baden, L.R., 2012
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011
HIV Screening of Male Inmates During Prison Intake Medical Evaluation - Washington, 2006-2010
JAMA 306:1756-1757, Strick, L.B., 2011
Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011
Antiretroviral Prophylaxis: A Defining Moment in HIV Control
Lancet 378:e23-25, Karim, S.S. and Karim, Q.A., 2011
Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001
PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001
Decreasing Incidence of CNS AIDS-Defining Events Associated with Antiretroviral Therapy
Neurol 54:1856-1859, d'Arminion Monforte,A.,et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
HIV Infection-1
BMJ 314:487-491, 579-5831997., Cohn,J.A., 1997
1997 USPHS/IDSA Guidelines for Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
Ann Int Med 127:923-946, , 1997
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV:A Summary
Ann Int Med 124:349-361, 3421996., , 1996
Primary Prevention of Cryptococcal Meningitis by Fluconazole in HIV Infected Patients
Lancet 345:548-552, 5301995., Quagliarello,V.J.,et al, 1995
Twice-Weekly Mainten Therapy with Sulfadiazine-Pyrimethamine to Prevent Recurr Toxo Enceph in AIDS Pts
Ann Int Med 123:175-180, Podzamczer,D.,et al, 1995
AIDs Risk Behaviors Among Late Middle-Aged and Elderly Americans
Arch Int Med 154:57-63, 191994., Stall,R.&Catania,J., 1994
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS
Ann Int Med 117:106-111, 163-1641992., Carr,A.,et al, 1992